Immatics at CAR-T Congress EU and Vein-To-Vein Congress EU (Jan 28-30) in London, UK

| News, USA

Discovery, Translation, Commercialization: Developing CAR-T into viable, accessible therapies

Tackling the manufacturing, scale-up, regulatory and logistical bottlenecks to commercialize cell therapies for the mainstream

Meet Immatics at the combined congresses CAR-T EU and Vein-To-Vein EU in London and discuss cell therapy manufacturing innovations: From streamlining logistics to scaling and automating manufacturing processes and developing robust raw material supply chains to get a viable, accessible therapy.

 

Tuesday, Jan 28, 9.30am-10.30am 

CAR-T Congress EU 

Panel: Process development and preparation for upscaling manufacturing for clinical and commercial manufacturing – what are the considerations right now?

Moderator and Panelist: Ali Mohamed, VP CMC Immatics US 

 

Tuesday, Jan 28, 11.45am-12.30pm 

Vein-To-Vein Congress EU 

Panel: CMO or In-House: what’s best for your growth plan?

Panelist: Ali Mohamed, VP CMC Immatics US 

 

Wednesday, Jan 29, 2.45-3.15pm 

Vein-To-Vein Congress EU 

Talk: Cutting Vein to Vein time to 10 days when manufacturing younger cells

Chair and Speaker: Ali Mohamed, VP CMC Immatics US 

 

We are looking forward to seeing you there.

Further information on Vein-To-Vein Congress EU Congress here.
Further information on CAR-T Congress EU here.

Press Contact

Anja Heuer

Corporate Communications,
Immatics Biotechnologies GmbH

+49 89 540 415 606

Go back

We use cookies to ensure that we give you the best experience on our website.